|FROM ||firstname.lastname@example.org (Dave_att)
|SUBJECT ||Re: [NYLXS - HANGOUT] Rx Ripoff
|From owner-hangout-at-mrbrklyn.com Fri Apr 29 17:38:59 2005
Received: from www2.mrbrklyn.com (localhost [127.0.0.1])
by www2.mrbrklyn.com (8.13.1/8.13.1/SuSE Linux 0.7) with ESMTP id j3TLcvcX018286
for ; Fri, 29 Apr 2005 17:38:59 -0400
Received: (from majordomo-at-localhost)
by www2.mrbrklyn.com (8.13.1/8.13.1/Submit) id j3TLcvAw018285
for hangout-outgoings; Fri, 29 Apr 2005 17:38:57 -0400
X-Authentication-Warning: www2.mrbrklyn.com: majordomo set sender to owner-hangout-at-nylxs.com using -f
Received: from mtiwmhc12.worldnet.att.net (mtiwmhc12.worldnet.att.net [184.108.40.206])
by www2.mrbrklyn.com (8.13.1/8.13.1/SuSE Linux 0.7) with ESMTP id j3TLcs98018282
for ; Fri, 29 Apr 2005 17:38:56 -0400
Received: from 220.127.116.11 ([18.104.22.168])
by worldnet.att.net (mtiwmhc12) with SMTP
id <2005042917401311200llukve>; Fri, 29 Apr 2005 17:40:17 +0000
Received: from [22.214.171.124] by 126.96.36.199;
Fri, 29 Apr 2005 17:40:11 +0000
From: dspira-at-att.net (Dave_att)
To: Ron Guerin ,
"Michael L. Richardson"
Subject: Re: [NYLXS - HANGOUT] Rx Ripoff
Date: Fri, 29 Apr 2005 17:40:11 +0000
X-Mailer: AT&T Message Center Version 1 (Feb 14 2005)
this is obviously a smear campaign against the pharmaceutical industrty. A pharmacist knows his business depends on his customers. would they chance ruining their business by overcharging on a non generic medication? It makes no sense.
-------------- Original message ----------------------
From: Ron Guerin
> Michael L. Richardson wrote:
> > I don't know how true this is.
> I wouldn't put too much stock in it, for if it comes from a budget
> analyst for the Dept. of Commerce, then she knows she's prepared a
> deliberately misleading report that opens with a scandalous chart about
> non-generic drugs and then goes on to complain about the cost of the
> The cost of the non-generics, which is what she's trying to enrage
> people with has little to nothing to do with the cost of the active
> ingredient itself, and everything to do with the cost of discovering/
> creating the drug, testing it, and accounting for potential liability.
> I have little doubt we're being ripped off, but this piece is garbage.
> - Ron